GGrantIndex
Sort

48,018 grants matching immunotherapy

Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma

$498,957
Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA

Enhancing the Potency and Durability  of Immunotherapies

$498,946
Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2019 · CA

Small Animal Radiation Research Platform with Cone-beam CT Guidance

$498,925
James M Larner · University Of Virginia · S10 · FY2010 · RR

Genetic dissection of Id3-mediated pathways in gamma/delta lineage development

$498,901
Yuan Zhuang · Research Inst Of Fox Chase Can Ctr · P01 · FY2014 · AI

Androgen Activation of Innate Immune Signaling to Enhance Prostate Cancer Immune Response

$498,873
Sushant Krishna Kachhap · Johns Hopkins University · R01 · FY2024 · CA

Mechanisms by which effector T cells modulate endogenous remyelination

$498,784
Peter A Calabresi · Johns Hopkins University · R01 · FY2023 · NS

Data Analysis Unit

$498,776
Gad A Getz · Dana-Farber Cancer Inst · U2C · FY2021 · CA

Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer

$498,691
Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer

$498,691
Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells

$498,670
Yuri Sykulev · Thomas Jefferson University · U01 · FY2024 · AI

A her-2/neu Pulsed DC1 Vaccine for Patients with DCIS

$498,655
University Of Pennsylvania · R01 · FY2004 · CA

GAIPO: graph artificial intelligence for pediatric oncology

$498,601
Kelvin P Lee · Indiana University Indianapolis · P30 · FY2024 · CA

Peptide-mediated immunotherapy of KSHV-associated malignancy.

$498,591
Jae U Jung · University Of Southern California · RC1 · FY2010 · CA

Effector T Cell Trafficking in Ovarian Cancer

$498,552
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

Iron oxide nanotheranostics for breast cancer

$498,525
Miqin Zhang · University Of Washington · R01 · FY2019 · EB

Fecal Microbiota Transplant and PD-1 blockade in Melanoma

$498,492
Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA

Targeting the innate immune response in HNSCC

$498,386
Judith A. Varner · University Of California, San Diego · R01 · FY2025 · DE

Targeting the innate immune response in HNSCC

$498,386
Judith A. Varner · University Of California, San Diego · R01 · FY2022 · DE

Targeting the innate immune response in HNSCC

$498,386
Judith A. Varner · University Of California, San Diego · R01 · FY2023 · DE

Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma

$498,337
Stephen C Mack · St. Jude Children'S Research Hospital · U01 · FY2025 · CA

Chemokine Modulation During SIV Infection & AIDS

$498,326
Todd A Reinhart · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · AI

Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma

$498,307
Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA

The role of Tumor associated macrophages in glioblastoma

$498,283
Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · NS

The role of Tumor associated macrophages in glioblastoma

$498,283
Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS

Optimized ultrasound-enhanced immunotherapy

$498,279
Katherine W Ferrara · University Of California At Davis · R01 · FY2015 · CA